Approval · Notice of Compliance 16309 · 2014
VAL-VANCOMYCIN: Notice of Compliance 16309
Issued November 17, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16309
- Date
- November 17, 2014
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Merger - buyout
- Therapeutic class
- Antibiotic
- Canadian reference product
- STERILE VANCOMYCIN HYDROCHLORIDE USP (Hospira Healthcare Corporation)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VAL-VANCOMYCIN | 02342855 | Marketed |
| VAL-VANCOMYCIN | 02342863 | Marketed |
| VAL-VANCOMYCIN | 02405822 | Marketed |
| VAL-VANCOMYCIN | 02405830 | Marketed |
Medicinal ingredients
- VANCOMYCIN HYDROCHLORIDE 500 MG per VIAL
- VANCOMYCIN HYDROCHLORIDE 1 G per VIAL
- VANCOMYCIN HYDROCHLORIDE 5 G per VIAL
- VANCOMYCIN HYDROCHLORIDE 10 G per VIAL